Canadian usage of clopidogrel following hospitalization falls short Smoking cessation drug has promise in cardiac patientsOttawa researchers also report success with their program for quitting smoking Adverse Reactions: Sibutramine - increased cardiovascular risks Sibutramine voluntarily withdrawn from Canadian and American markets in October 2010. Adverse Reactions: Clopidogrel–PPI interaction revisited Some proton pump inhibitors may be associated with a decrease in the antiplatelet effect of clopidogrel and an increased risk of cardiac events. Window to the world Calcium channel blocker–macrolide interaction: dangerous and underappreciated Azithromycin preferred in older patients receiving a CCB. Pomegranate may benefit dialysis patients Study links the fruit’s juice with reduced inflammation and hospitalizations due to infections and heart troubles Avoid statins in patients with intracerebral hemorrhage Uncertain whether statins advisable in patients at high risk for ICH. New drugs get a rise out of HDL Phase II trials look promising, but larger outcome studies needed Cholesterol deposits on eyelids give insight into heart disease The eyes have it—a clue to heart disease, that is. First Previous 69 70 71 72 73 Next Last
